Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Vanguard

VGHCX Holdings: What Vanguard Health Care Fund Owns

Ticker VGHCX · · Holdings as of Jul 31, 2026

Expense ratio
0.33%$33/yr per $10k
5-yr return
+6.6%annualized
1-yr return
+17.3%as of Dec 2025
Net assets
$38.2Ball share classes
Holdings
97

Bottom line

What does VGHCX hold?

VGHCX held 97 positions as of Jul 31, 2026. Its largest holding is Eli Lilly & Co at 8.61% of the fund, and the top 10 positions add up to 40.6%. By asset type it is 98% stocks, 2% repurchase agreements, 0% cash & short-term funds.

Updated Sep 28, 2026

VGHCX top 25 holdings

#HoldingType% of fundValue
1 Eli Lilly & Co
ELI LILLY & CO
Stocks 8.61%$3.3B
2 Merck & Co Inc
MERCK & CO
Stocks 5.44%$2.1B
3 Johnson & Johnson
JOHNSON&JOHNSON
Stocks 4.83%$1.8B
4 AstraZeneca PLC
ASTRAZENECA PLC
Stocks 4.59%$1.8B
5 UnitedHealth Group Inc
UNITEDHEALTH GRP
Stocks 4.05%$1.5B
6 Gsk Plc Stocks 3.00%$1.1B
7 Edwards Lifesciences Corp
EDWARDS LIFE
Stocks 2.56%$977.6M
8 Intuitive Surgical Inc
INTUITIVE SURGIC
Stocks 2.52%$963.0M
9 CVS Health Corp
CVS HEALTH CORP
Stocks 2.52%$961.8M
10 Cencora Inc
CENCORA INC
Stocks 2.47%$944.6M
11 Vertex Pharmaceuticals Inc
VERTEX PHARM
Stocks 2.36%$901.8M
12 AbbVie Inc
ABBVIE INC
Stocks 2.30%$879.8M
13 Danaher Corp
DANAHER CORP
Stocks 2.18%$833.6M
14 Regeneron Pharmaceuticals Inc
REGENERON PHARM
Stocks 2.14%$817.7M
15 Novartis AG
NOVARTIS AG-REG
Stocks 1.91%$728.6M
16 Elevance Health Inc
ELEVANCE HEALTH
Stocks 1.83%$698.4M
17 Argenx SE
ARGENX SE
Stocks 1.68%$642.1M
18 HCA Healthcare Inc
HCA HEALTHCARE I
Stocks 1.68%$641.7M
19 Ucb Sa Stocks 1.67%$637.1M
20 Boston Scientific Corp
BOSTON SCIENTIFC
Stocks 1.53%$582.9M
21 Agilent Technologies Inc
AGILENT TECH INC
Stocks 1.49%$570.1M
22 Biogen Inc
BIOGEN INC
Stocks 1.46%$557.2M
23 Galderma Group AG
GALDERMA GROUP A
Stocks 1.37%$524.5M
24 Roche Holding AG
ROCHE HOLDING AG-GENUSSCHEIN - PART.CERTIFICATES
Stocks 1.18%$450.1M
25 Dexcom Inc
DEXCOM
Stocks 1.18%$449.3M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026

Asset mix

Stocks97.6%
Repurchase agreements2.2%
Cash & short-term funds0.1%

Country exposure

BE3.4%
CH4.5%
DK1.4%
GB7.6%
HK0.8%
JP4.8%
US77.6%